In the lymph node metastases/lymph node metastases-paired samples group, 6 gain-of-function mutations were observed with only one being pathogenic (APC), 1 VUS (NF1) and 4 unclassified. This evidence concerns the gene NF1 and metastatic malignant neoplasm in the lymph nodes.